Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers.

In the assessment of 12-month price targets, analysts unveil insights for 10x Genomics, presenting an average target of ...

10x Genomics has launched its initial public offering (IPO), raising an estimated $357.5 million in net proceeds, then seeing its share price climb up to 48% in first-day trading. The IPO comes a day ...

If you are trying to work out whether 10x Genomics is attractively priced or already reflecting a lot of optimism, the starting point is understanding how its current market value lines up with the ...

10x Genomics reported 18% YoY revenue growth in Q4, reaching $184M, with instruments revenue seeing a remarkable surge of 71%. The company celebrated the successful launch of its cutting-edge platform ...

Forbes contributors publish independent expert analyses and insights. Steven covers accessibility and assistive technologies. Aug 07, 2023, 01:54pm EDT Aug 07, 2023, 03:58pm EDT This article is more ...

10x Genomics is a life science technology company with a clear mission and visionary leadership. 10x Genomics delivered a solid Q3 quarter with revenue reaching $154M, growing 17% YoY. The company has ...

"I am incredibly proud of the tenacity and ingenuity our team displayed throughout 2025," said Serge Saxonov, Co-founder and CEO of 10x Genomics. "While the macro environment was challenging, the team ...

Investors usually find it discouraging when an analyst cuts the price target on one of their stocks. In this instance, the cut to this company's shares was rather deep. It wasn't immediately apparent ...

SPT Labtech and 10x Genomics have partnered to provide automated workflows for single cell research. The collaboration will allow scientists to scale experiments on 10x’s Chromium Single Cell platform ...

Sept 14 (Reuters) - Genomics startup Parse Biosciences lost its bid to dismiss a patent-infringement lawsuit brought by rival 10x Genomics (TXG.O), opens new tab and Stanford University on Thursday, ...

10x Genomics (NASDAQ: TXG), a biotechnology company that designs and manufactures gene sequencing technology, was listed following its IPO in September. While the stock saw some volatility post its ...